findmyKOL
Clinical trialNCT01737619Active, not recruitingInterventional

PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer

SponsorM.D. Anderson Cancer CenterEnrollment101Endometrial Clear Cell AdenocarcinomaEndometrial Mixed AdenocarcinomaEndometrial Serous AdenocarcinomaGrade 3 Endometrial Endometrioid AdenocarcinomaMalignant Mixed Mesodermal (Mullerian) Tumor
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Lyndon Baines Johnson General Hospital

    Houston, Texas, United States

  • M D Anderson Cancer Center

    Houston, Texas, United States

  • Md Anderson Regional Care Center-Katy

    Houston, Texas, United States

  • the Woman'S Hospital of Texas

    Houston, Texas, United States

  • Md Anderson Regional Care Center-Bay Area

    Nassau Bay, Texas, United States

  • Md Anderson Regional Care Center-Sugar Land

    Sugar Land, Texas, United States

  • Md Anderson Regional Care Center-the Woodlands

    The Woodlands, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
3 Apr 2013
Primary completion
30 Apr 2025
Completion
31 Dec 2028
Last update posted
4 May 2026
Registered enrollment
101
Registry id
NCT01737619

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.